Jennifer M. Kissner
Senior Vice President of Clinical Development & Regulatory AffairsDr. Jennifer M. Kissner, Ph.D. serves as Senior Vice President of Clinical Development and Regulatory Affairs at Outlook Therapeutics, Inc. Dr. Kissner had been Vice President of Clinical Development at Clearside BioMedical, Inc. since August 01, 2016 until April 2019. Dr. Kissner was responsible for leading the Clearside BioMedical’s clinical development strategy and team efforts with all aspects of the design, implementation, execution and management of clinical trial programs. Dr. Kissner joined Clearside in August 2014 as Senior Director, Development and has led Clearside’s drug development programs for macular edema associated with non-infectious uveitis and wet age-related macular degeneration (AMD), which is in pre-clinical development with an Investigational New Drug (IND) submission to the U.S. Food and Drug Administration expected in the second half of 2016. Dr. Kissner has vast of clinical development experience for entities addressing sight-threatening diseases in positions at ophthalmology companies such as Alcon and Acucela.
Positions
- Company NameOutlook Therapeutics, Inc.Stock CodeOTLKPositionSenior Vice President of Clinical Development & Regulatory AffairsColleagues
- RCRobert Charles JahrPresident, CEO & Director
- FGFaisal G. SukhtianIndependent Chairman of the Board
- KLKevin LundquistCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- JPJoel PrieveSenior Vice President of Licensing and M&A
- SSSurendra SharmaSenior Vice President of Medical Affairs
- KJKurt J. HilzingerIndependent Director
- RHRalph H. ThurmanLead Independent Director
- YMYezan M. HaddadinIndependent Director
